… This report describes the 2-year (and longer) clinical outcomes and echocardiographic
findings after TAVR or surgical aortic-valve replacement in the high-risk patients in the PARTNER …

… Our 1-year clinical and echocardiographic outcomes suggest that transapical transcatheter
aortic valve implantation is a viable alternative to conventional aortic valve replacement in …

… In addition, PARTNER cohort A results showed that 1-year outcomes after TAVI compare
favourably with surgical aortic valve replacement. While a number of large single-arm registries …

… We report the 1-year clinical outcomes of aortic valve replacement with the EDWARDS
INTUITY Valve System (Edwards Lifesciences LLC, Irvine, Calif) in the Surgical Treatment of …

… 1, have been described previously. We now present the 1-year outcomes of this cohort. … in
the real world, document 1-year outcomes, and potentially predict outcomes in terms of a TAVI …

… report clinical outcomes following transcatheter aortic valve implantation (TAVI), using the
CoreValve revalving system (18 Fr transfemoral or subclavian) or the Edwards Sapien valve (…

… Transcatheter aortic valve implantation (TAVI) with the Cribier-Edwards prosthesis may
provide an alternative to conventional aortic valve replacement in high-risk patients with aortic …

… candidates for aortic-valve replacement with the use of a bioprosthetic valve. An Edwards
Lifesciences surgical bioprosthesis was recommended; mechanical valve prostheses were not …

… new pacemaker implantation (NPMI) after surgical aortic valve replacement (SAVR) and
transcatheter aortic valve replacement (TAVR), and investigate its influence on 1-year mortality. …

… higher than in the PARTNER I (Placement of Aortic Transcatheter Valves) trial (15). In the
present analysis of the 1-year outcomes of these patients, we found a high mortality rate of 53.7…